Risk-based treatment approaches for neuroblastoma have been ongoing for decades. However, the criteria used to define risk in various institutional and cooperative groups were disparate, limiting the ...

Please provide your email address to receive an email when new articles are posted on . Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...